Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy - Lentz, S R; Misgav, M; Ozelo, M (Haemophilia, 2013)